Are the effects of gambling treatment overestimated?

International Journal of Mental Health and Addiction

Volumn 5, Issue 1, 2007, Pages 65-79

  Westphal, James R ^a,b  

^a UNIVERSITY OF HAWAII   (United States)

^b Hawaii State Hospital   (United States)

Author keywords

Evaluation of evidence for problem gambling treatment; Problem gambling treatment; Problem gambling treatment retention

Indexed keywords

EID: 33846881836     PISSN: 15571874     EISSN: 15571882     Source Type: Journal    
DOI: 10.1007/s11469-006-9038-4     Document Type: Article

References (72)

1. Baekeland, F., & Lundwall, L. (1975). Dropping out of treatment: A critical review. Psychological Bulletin, 82(5), 738-783 (Sep.).
2. Blaszczynski, A., & Silove, D. (1995). Cognitive and behavioral therapies of pathological gambling. Journal of Gambling Studies, 11, 195-219.
3. Boutron, I., Tubach, F., Giraudeau, B., & Ravaud, P. (2004). Blinding was judged more difficult to achieve and maintain in nonpharmacologic than pharmacologic trials. Journal Of Clinical Epidemiology, 57(6), 543-550 (Jun.).
4. Brody, H. (2000). The placebo response. Recent research and implications for family medicine. Journal of Family Practice, 49(7), 649-654 (Jul.).
5. Carey, T. S., & Boden, S. D. (2003). A critical guide to case series reports. Spine, 28(15), 1631-1634 (Aug. 1).
6. Chambless, D. L., & Ollendick, T. H. (2001). Empirically supported psychological interventions: Controversies and evidence. Annual Review of Psychology, 52, 685-716.
7. Coronary Drug Project Research Group (1980). Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project. New England Journal of Medicine, 303(18), 1038-1041 (Oct. 30).
8. Crockford, D. N, & el-Guebaly, N. (1998). Psychiatric comorbidity in pathological gambling: A critical review. Canadian Journal of Psychiatry, 43(1), 43-50.
9. Davidson, K. W., Goldstein, M., Kaplan, R. M., Kaufmann, P. G., Knatterud, G. L., Orleans, C. T., et al. (2003) Evidence-based behavioral medicine: what is it and how do we achieve it? Annals of Behavioral Medicine, 26(3), 161-171 (Dec.).
10. Deeks, J. J., Dinnes, J., D'Amico, R., Sowden, A. J., Sakarovitch, C., Song, F., International Stroke Trial Collaborative Group; European Carotid Surgery Trial Collaborative Group et al. (2003). Evaluating non-randomised intervention studies. Health Technology Assessment, 7(27), iii-x, 1-173.
11. Delgado-Rodriguez, M., & Llorca, J. (2004). Bias. Journal of Epidemiology and Community Health, 58(8), 635-641 (Aug.).
12. Dickerson, M., Hinchy, J., & England, S. L. (1990) Minimal treatments and problem gamblers: A preliminary investigation. Journal of Gambling Studies, 6(1), 87-101.
13. Djulbegovic, B., Cantor, A., & Clarke, M. (2003). The importance of preservation of the ethical principle of equipoise in the design of clinical trials: Relative impact of the methodological quality domains on the treatment effect in randomized controlled trials. Accountability in Research, 10(4), 301-315 (Oct.-Dec.).
14. Doig, G. S., & Simpson, F. (2005). Randomization and allocation concealment: A practical guide for researchers. Journal of Critical Care, 20(2), 187-191; discussion 191-193 (Jun.).
15. Echeburua, E., Baez, C., & Fernandez-Montalvo, J. (1996). Comparative effectiveness of three therapeutic modalities in the psychological treatment of pathological gambling. Behavioral and Cognitive Psychotherapy, 24, 51-72.
16. Edlund, M. J., Wang, P. S., Berglund, P. A., Katz, S. J., Lin, E., & Kessler, R. C. (2002). Dropping out of mental health treatment: Patterns and predictors among epidemiological survey respondents in the United States and Ontario. American Journal of Psychiatry, 159(5), 845-851 (May).
17. Evans, L., & Delfabbro, P. H. (2005). Motivators for change and barriers to help-seeking in Australian problem gamblers. Journal of Gambling Studies, 21(2), 133-155 (Summer).
18. Fergusson, D., Glass, K. C., Waring, D., & Shapiro, S. (2004). Turning a blind eye: The success of blinding reported in a random sample of randomised, placebo controlled trials. British Medical Journal, 328(7437), 432. Epub 2004 (Jan. 22 & Feb. 21).
19. Goldberg, R. J., Leigh, H., & Quinlan, D. (1979) The current status of placebo in hospital practice. General Hospital Psychiatry, 1(3), 196-201 (Sep.).
20. Grant, J. E., Kim, S. W., & Kuskowski, M. (2004). Retrospective review of treatment retention in pathological gambling. Comprehensive Psychiatry, 45(2), 83-87 (Mar.-Apr.).
21. Greenberg, D., & Rankin, H. (1982). Compulsive gamblers in treatment. British Journal of Psychiatry, 140, 364-366 (Apr.).
22. Grimes, D. A., & Schulz, K. F. (2002a). An overview of clinical research: The lay of the land. Lancet, 359(9300), 57-61 (Jan. 5).
23. Grimes, D. A., & Schulz, K. F. (2002b). Descriptive studies: What they can and cannot do. Lancet, 359(9301), 145-149 (Jan. 12).
24. Hahn, R. (1997). The nocebo phenomenon: Concept, evidence, and implications for public health. Preventive Medicine, 26(5 Pt 1), 607-611 (Sep.-Oct.).
25. Harbour, R., & Miller, J. (2001). A new system for grading recommendations in evidence based guidelines. British Medical Journal, 323, 334-336.
26. Hodgins, D. C., Currie, S. R., & el-Guebaly, N. (2001). Motivational enhancement and self-help treatments for problem gambling. Journal of Consulting and Clinical Psychology, 69(1), 50-57 (Feb.).
27. Hoffman, J. R. (1999). Rethinking case reports. Western Journal of Medicine, 170(5), 253-254 (May).
28. Hollander, E., Pallanti, S., Allen, A., Sood, E., & Baldini Rossi, N. (2005). Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders? American Journal of Psychiatry, 162(1), 137-145 (Jan.).
29. Hyland, M. E. (2003). Using the placebo response in clinical practice. Clinical Medicine, 3(4), 347-350 (Jul.-Aug.).
30. Ioannidis, J. P., Haidich, A. B., Pappa, M., Pantazis, N., Kokori, S. I., Tektonidou, M. G., et al. (2001). Comparison of evidence of treatment effects in randomized and nonrandomized studies. Journal of American Medical Association, 286(7), 821-830 (Aug. 15).
31. Juni, P., Altman, D. G., & Egger, M. (2001a). Systematic reviews in health care: Assessing the quality of controlled clinical trials. British Medical Journal, 323(7303), 42-46 (Jul. 7).
32. Juni, P., Altman, D. G., & Egger, M. (2001b). Assessing the quality of controlled clinical trials. In M. Egger, G. Davey Smith & D. G. Altman (Eds.), Systematic reviews in health care: Meta-analysis in context, 2nd edn. London: BMJ.
33. Kaptchuk, T. J. (2002). The placebo effect in alternative medicine: Can the performance of a healing ritual have clinical significance? Annuals of Internal Medicine, 136(11), 817-825 (Jun 4).
34. Kennedy, K. A., & Frankowski, R. F. (2003). Evaluating the evidence about therapies. What the clinician needs to know about statistics. Clinical Perinatology, 30(2), 205-215 (Jun.).
35. Kim, S. W., Grant, J. E., Adson, D. E., & Shin, Y. C. (2001). Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling. Biological Psychiatry, 49(11), 914-921 (Jun. 1).
36. Ladouceur, R.,Gosselin, P., LaBerge, M., & Blaszczynski, A. (2001a) Drop-outs in clinical research: Do results reported in field of addiction reflect clinical reality? The Behavioral Therapist, 24, 44-46.
37. Ladouceur, R., Sylvain, C., Boutin, C., Lachance, S., Doucet, C., Leblond, J., et al. (2001b). Cognitive treatment of pathological gambling. Journal of Nervous and Mental Disease, 189(11), 774-780 (Nov.).
38. Ladouceur, R., Sylvain, C., Boutin, C., Lachance, S., Doucet, C., & Leblond, J. (2003). Group therapy for pathological gamblers: A cognitive approach. Behavior Research and Therapy, 41(5), 587-596 (May).
39. Leblond, J., Ladouceur, R., & Blaszczynski, A. (2003). Which pathological gamblers will complete treatment? British Journal of Clinical Psychology, 42(Pt 2), 205-209 (Jun.).
40. Lopez Viets, V. C., & Miller, W. R. (1997). Treatment approaches for pathological gamblers. Clinical Psychology Review, 17(7), 689-702 (Nov.).
41. Macedo, A., Farre, M., & Banos, J. E. (2003). Placebo effect and placebos: What are we talking about? Some conceptual and historical considerations. European Journal of Clinical Pharmacology, 59(4), 337-342. Epub 2003 (Jun. 27, Aug.).
42. Moher, D., Altman, D. G., Schulz, K. F., & Elbourne, D. R. (2004). Opportunities and challenges for improving the quality of reporting clinical research: CONSORT and beyond. Canadian Medical Association Journal, 171(4), 349-350 (Aug. 17).
43. Moher, D., Schulz, K. F., & Altman, D. G., for the CONSORT Group (2001). The CONSORT statement: Revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet, 357, 1191-1194.
44. Moeller, F. G., Dougherty, D. M., Barratt, E. S., Schmitz, J. M., Swann, A. C., & Grabowski, J. (2001). The impact of impulsivity on cocaine use and retention in treatment. Journal of Substance Abuse Treatment, 21(4), 193-198 (Dec.).
45. Montori, V. M., Bhandari, M., Devereaux, P. J., Manns, B. J., Ghali, W. A., & Guyatt, G. H. (2002). In the dark: The reporting of blinding status in randomized controlled trials. Journal of Clinical Epidemiology, 55(8), 787-790 (Aug.).
46. National Responsible Gambling Program (2005). Annual Report 2004. Available at: http://www.responsiblegambling.co.za, accessed on 9/7/05.
47. Oakley-Browne, M. A., Adams, P., & Mobberley, P. M. (2000). Interventions for pathological gambling. Cochrane Database Systematic Reviews, (2), CD001521.
48. Oh, V. M. (1991). Magic or medicine? Clinical pharmacological basis of placebo medication. Annuals Academy Medicine Singapore, 20(1), 31-37 (Jan.).
49. Papakostas, Y. G., & Daras, M. D. (2001). Placebos, placebo effect, and the response to the healing situation: The evolution of a concept. Epilepsia, 42(12), 1614-1625 (Dec.).
50. Petry, N. M. (2005). Stages of change in treatment-seeking pathological gamblers. Journal of Consulting and Clinical Psychology, 73(2), 312-322 (Apr.).
51. Petry, N. M., Stinson, F. S., & Grant, B. F. (2005). Comorbidity of DSM-IV pathological gambling and other psychiatric disorders: Results from the national epidemiologic survey on alcohol and related conditions. Journal of Clinical Psychiatry, 66(5), 564-574 (May).
52. Reeves, B. C. (2004). Reasons for caution when evaluating health care interventions using non-randomised study designs. Forsch Komplementarmed Klass Naturheilkd, 11(Suppl 1), 40-45 (Aug.).
53. Robson, E., Edwards, J., Smith, G., & Colman, I. (2002). Gambling decisions: An early intervention program for problem gamblers. Journal of Gambling Studies, 18(3), 235-255 (Fall).
54. Rockloff, M. J., & Schofield, G. (2004). Factor analysis of barriers to treatment for problem gambling. Journal of Gambling Studies, 20(2), 121-126.
55. Sackett, D. L., & Gent, M. (1979). Controversy in counting and attributing events in clinical trials. New England Journal of Medicine, 301(26), 1410-1412 (Dec. 27).
56. Sackett, D. L., Richarson, W. S., Rosenberg, W., & Haynes, R. B. (1998). Evidence based medicine how to practice and teach EBM. Edinburgh, Scotland: Churchill Livingstone.
57. Saiz-Ruiz, J., Blanco, C., Ibanez, A., Masramon, X., Gomez, M. M., Madrigal, M., et al. (2005). Sertraline treatment of pathological gambling: A pilot study. Journal of Clinical Psychiatry, 66(1), 28-33 (Jan.).
58. Schulz, K. F., Chalmers, I., Hayes, R. J., & Altman, D. G. (1995). Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. Journal of American Medical Association, 273, 408-412.
59. Shaffer, H. J., Labrie, R. A., Laplante, D. A., Kidman, R. C., & Donato, A. N. (2005). The Iowa gambling treatment program: Treatment outcomes for a follow-up sample. Journal of Gambling Studies, 21(1), 59-71 (Spring).
60. Shepherd, M. (1993). The placebo: From specificity to the non-specific and back. Psychological Medicine, 23(3), 569-578 (Aug.).
61. Sibbald, B., & Roland, M. (1998). Understanding controlled trials. Why are randomised controlled trials important? British Medical Journal, 316(7126), 201 (Jan 17).
62. Stewart, R. M., & Brown, R. I. (1988). An outcome study of Gamblers Anonymous. British Journal of Psychiatry, 152, 284-288 (Feb.).
63. Stinchfield, R., & Winters, K. C. (2001). Outcome of Minnesota's gambling treatment programs. Journal of Gambling Studies, 17(3), 217-245 (Fall).
64. Stone, D. A., Kerr, C. E., Jacobson, E., Conboy, L. A., & Kaptchuk, T. J. (2005). Patient expectations in placebo-controlled randomized clinical trials. Journal Evaluation of Clinical Practice, 11(1), 77-84 (Feb.).
65. Straus, J. L., & von Ammon Cavanaugh, S. (1996). Placebo effects. Issues for clinical practice in psychiatry and medicine. Psychosomatics, 37(4), 315-326 (Jul-Aug.).
66. Toneatto, T., & Ladouceur, R. (2003). Treatment of pathological gambling: A critical review of the literature. Psychology of Addictive Behaviors, 42, 92-99.
67. Toneatto, T., & Millar, G. (2004). Assessing and treating problem gambling: Empirical status and promising trends. Canadian Journal of Psychiatry, 49(8), 517-525 (Aug.).
68. Vandenbroucke, J. P. (2001). In defense of case reports and case series. Annuals of Internal Medicine, 134(4), 330-334 (Feb 20).
69. Walker, M. B. (1992). The psychology of gambling. Oxford, England: Pergamon.
70. Walach, H., & Jonas, W. B. (2004). Placebo research: The evidence base for harnessing self-healing capacities. Journal of Alternative and Complementary Medicine, 10(Suppl 1), S103-S112.
71. Welte, J., Barnes, G., Wieczorek, W., Tidwell, M. C., & Parker, J. (2001). Alcohol and gambling pathology among U.S. adults: Prevalence, demographic patterns and comorbidity. Journal of Studies of Alcoholism, 62(5), 706-712 (Sep.).
72. Zlowodzki, M., Jonsson, A., & Bhandari, M. (2006). Common pitfalls in the conduct of clinical research. Medical Principles and Practices, 15(1), 1-8.